Balanced news tone
News Sentiment
GMED sentiment intelligence
Globus Medical news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
78/100 classification confidence.
directly relevant articles
high-authority source matches
-2.5% over one week, -2.8% over four weeks, trend inactive, and near fair-value range.
Globus Medical to Announce Second Quarter 2026 Financial Results on August 6
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Globus Medical to Announce Second Quarter 2026 Financial Results on August 6
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 Jul 2026 20:42
- Source
- Quiver Quantitative
Globus Medical Sets Aug. 6 Call on Second-Quarter Results
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 Jul 2026 20:31
- Source
- Stock Titan
Globus Medical Schedules Second Quarter Earnings Release and Conference Call
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 Jul 2026 20:30
- Source
- GlobeNewswire
Truist Adjusts Price Target on Globus Medical to $100 From $115, Maintains Buy Rating
- Tone
- Positive 58/100
- Event
- Analyst action
- Published
- 16 Jul 2026 13:23
- Source
- MT Newswires
Globus Medical (GMED) Stock Still Looks Undervalued Despite A 39% Return
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 09:14
- Source
- Market source
Globus Medical (GMED) Stock Looks Like A Bargain At This Price
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 03:02
- Source
- simplywall.st
Globus Medical Inc (GMED) Stock Down 4.9% -- Now Undervalued? GF Score: 97/100
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 22:47
- Source
- GuruFocus
Globus Medical (GMED) Falls as Recent Analyst Caution Appears to Weigh on Shares
- Tone
- Negative 34/100
- Event
- Analyst action
- Published
- 14 Jul 2026 21:20
- Source
- Quiver Quantitative
Reflecting On Medical Devices & Supplies - Specialty Stocks’ Q1 Earnings: Integer Holdings (NYSE:ITGR)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 Jul 2026 18:07
- Source
- Market source
Is Globus Medical (GMED) Undervalued Or Is Its Robotics Growth Already Priced In?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 11 Jul 2026 18:31
- Source
- simplywall.st
Globus Medical Inc - A (NYSE:GMED) Screens Well as a GARP Stock with Strong Growth and Reasonable Valuation
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 10 Jul 2026 12:40
- Source
- ChartMill
What Globus Medical (GMED)'s Robotics-Focused Institutional Interest Means For Shareholders
Globus Medical (GMED) has seen increased institutional interest due to its focus on robotics, navigation, and minimally invasive procedures, particularly its ExcelsiusGPS ecosystem. This renewed attention reinforces the company's investment narrative centered on durable growth fr
- Tone
- Positive 70/100
- Event
- Market update
- Published
- 07 Jul 2026 16:09
- Source
- Sahm
Globus Medical Inc focuses on spine technologies as investors watch long term growth
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 06 Jul 2026 16:27
- Source
- ad-hoc-news.de
Globus Medical (GMED) Secures FDA Clearances As Revenue And R And D Stay Strong
Globus Medical (GMED) has secured new FDA clearances, expanding its product offerings in spine and orthopedic surgery. This development, coupled with strong revenue growth and a steady commitment to R&D, positions the company as an innovative and high-growth investment, especiall
- Tone
- Positive 74/100
- Event
- Earnings
- Published
- 05 Jul 2026 02:39
- Source
- Sahm
Globus Medical Inc Class A Actuals & Estimates (GETTEX:GM0N)
This article provides actuals and estimates for Globus Medical Inc Class A (GM0N) traded on GETTEX, including its current stock price, historical performance, analyst forecasts, and financial data. It covers revenue, earnings per share, net income, market capitalization, and vola
- Tone
- Positive 64/100
- Event
- Earnings
- Published
- 02 Jul 2026 17:42
- Source
- TradingView
GMED vs. MDT: Which Medical Stock Has More Upside Potential?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 29 Jun 2026 07:00
- Source
- Market source
Globus Medical Inc Class A Actuals & Estimates (HAM:GM0N)
This article provides actuals and estimates for Globus Medical Inc Class A (HAM:GM0N), covering financial data from income statements, balance sheets, and cash flow statements, alongside analyst forecasts. It details the company's stock performance, market capitalization, earning
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 28 Jun 2026 10:39
- Source
- TradingView
Price to sales forward of Globus Medical Inc Class A – TRADEGATE:GM0N
This article provides the "Price to sales forward" for Globus Medical Inc Class A (GM0N) on the Tradegate Exchange. It highlights the current value, change, and percentage change for this financial metric. The information is presented within the context of TradingView's financial
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Jun 2026 09:10
- Source
- TradingView
How Globus Medical Inc. Class A (GMED) Affects Rotational Strategy Timing
This article analyzes Globus Medical Inc. Class A (GMED) using AI models to provide trading strategies for different risk profiles. It highlights a strong near-term sentiment shifting to a long-term positive bias, with an impressive 53.9:1 risk-reward setup. The analysis offers s
- Tone
- Positive 74/100
- Event
- Market update
- Published
- 28 Jun 2026 02:09
- Source
- Stock Traders Daily
Globus Medical Inc Class A Actuals & Estimates (FWB:GM0N)
This article provides an overview of Globus Medical Inc Class A (FWB:GM0N) stock, including its current price, market capitalization, historical performance, and analyst forecasts. It details financial actuals and estimates such as earnings per share and revenue for recent quarte
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 28 Jun 2026 01:10
- Source
- TradingView
GM0N Forecast — Price Target — Prediction for 2027
This article provides a forecast and price target for Globus Medical Inc Class A (GM0N) stock. It includes analyst ratings, earnings estimates, revenue expectations, and historical price performance, highlighting that analysts project a maximum price of 105.48 EUR and a minimum o
- Tone
- Positive 64/100
- Event
- Earnings
- Published
- 27 Jun 2026 13:09
- Source
- TradingView
Globus Medical (GMED) Stock After 47% One-Year Gain Is There More Room To Run
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 27 Jun 2026 07:00
- Source
- Market source
Globus Medical Inc Class A Actuals & Estimates (NYSE:GMED)
This article provides an overview of Globus Medical, Inc. (NYSE:GMED) stock, including its current price, performance trends, analyst forecasts, and financial data. It highlights the company's financial results, market capitalization, and upcoming earnings report, while emphasizi
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 27 Jun 2026 02:38
- Source
- TradingView
Globus Medical Inc Class A Actuals & Estimates (BX:GMED)
This article provides an overview of Globus Medical Inc Class A (GMED) stock, including its financial actuals and estimates. It details analyst price targets, past earnings and revenue, future earnings report dates, and key financial metrics like EBITDA. The article also provides
- Tone
- Positive 65/100
- Event
- Earnings
- Published
- 26 Jun 2026 23:39
- Source
- TradingView
Globus Medical updates guidance after NuVasive merger close, shares react on NASDAQ
Globus Medical has issued updated post-merger guidance following its all-stock acquisition of NuVasive, detailing revenue synergies, margin expectations, and integration costs for investors. The combined entity is poised to compete more directly with larger spine and orthopedics
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 26 Jun 2026 16:10
- Source
- Ad-hoc-news.de
GMED Forecast — Price Target — Prediction for 2027
This article provides a forecast for Globus Medical Inc Class A (GMED) stock, including analyst price targets, historical and estimated EPS and revenue, and other financial metrics. It details the stock's current price, volatility, market capitalization, upcoming earnings reports
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 26 Jun 2026 11:40
- Source
- TradingView
Globus Medical Inc Class A Actuals & Estimates (BMV:GMED)
This article provides an overview of Globus Medical Inc Class A (GMED) stock performance, financial estimates, and analyst forecasts on the Mexican Stock Exchange. It details current stock price, historical highs and lows, market capitalization, volatility, and upcoming earnings
- Tone
- Positive 62/100
- Event
- Earnings
- Published
- 26 Jun 2026 02:10
- Source
- TradingView
Price to earnings forward of Globus Medical Inc Class A – BIVA:GMED
This page displays the "Price to earnings forward" metric for Globus Medical Inc Class A (GMED) on the BIVA exchange. It indicates that the market was closed at the time of viewing, with no trades reported. The content also notes the data source and copyright information.
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Jun 2026 14:42
- Source
- TradingView
Globus Medical Inc Class A Actuals & Estimates (BOATS:GMED)
This article provides an overview of Globus Medical, Inc. (GMED) stock, focusing on its financial actuals and analyst estimates. It details the company's past earnings and revenue, future projections, stock price history, and key financial metrics like EBITDA. The article also co
- Tone
- Positive 62/100
- Event
- Earnings
- Published
- 25 Jun 2026 01:10
- Source
- TradingView
Earnings Beat Amid Currency Headwinds Might Change The Case For Investing In Globus Medical (GMED)
Globus Medical (GMED) reported better-than-expected Q1 2026 financial results, which positively influenced investor sentiment despite ongoing inflation, interest rate uncertainty, and foreign currency pressures. The company reaffirmed its full-year 2026 revenue guidance of US$3.1
- Tone
- Positive 71/100
- Event
- Earnings
- Published
- 24 Jun 2026 09:40
- Source
- Sahm